Earnings Ahead

NVCR - NovoCure

86.03 0.73 0.86

NovoCure

NovoCure

About

Profile

In 2000, Yoram Palti, our founder and professor emeritus of physiology and biophysics at the Technion — Israel Institute of Technology, sought to leverage his expertise in biophysics to develop a new way to treat solid tumor cancers that would destr


Headquarters

Jersey


Intraday

High
-
Low
-

52-week

High
-
Low
-

NVCR



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • NovoCure GAAP EPS of -$0.45 beats by $0.07, revenue of $133.78M in-line
  • NovoCure Q4 2023 Earnings Preview
  • NovoCure Tumor Treating Fields accepted for FDA review
  • Novocure reports better-than-expected preliminary Q4, FY revenue
  • Novocure appoints Nicolas Leupin as its chief medical officer
  • NovoCure gains on participation at J.P. Morgan Healthcare Conf.
  • Novocure to eliminate 13% of workforce in restructuring effort
  • NovoCure GAAP EPS of -$0.46 beats by $0.07, revenue of $127.32M misses by $1.44M
  • NovoCure Q3 2023 Earnings Preview
  • HC Wainwright cuts NovoCure to neutral in wake of failed study
  • Novocure falls after setback to Phase 3 trial for Tumor Treating Fields
  • NovoCure upgraded at Piper Sandler ahead of Phase 3 readout for TTFieds
  • NovoCure GAAP EPS of -$0.54 misses by $0.04, revenue of $126.05M beats by $1.8M
  • NovoCure Q2 2023 Earnings Preview
  • NovoCure upgraded at Wedbush citing balanced risk-reward setup
  • Why did NovoCure stock crash today? TTFields data
  • Hot Stocks: COIN falls as SEC files suit; GTLB gains on earnings; LAZR rises; NVCR slides
  • Novocure, Zai Lab post Phase 3 data for electric fields device in lung cancer
  • NovoCure gains as Wells Fargo upgrades on upcoming data readout
  • NovoCure GAAP EPS of -$0.50 misses by $0.16, revenue of $122.18M misses by $5.75M
Date Price Open High Low Vol Change ER
Apr 29 76.58 76.45
79.22
76.36
647.53K -0.78%
Apr 28 77.18 78.61
78.61
71.83
660.76K 0.30%
Apr 27 76.95 78.04
80.71
75.85
631.90K -1.3%
Apr 26 77.96 82.71
83.26
77.65
572.23K -6.44%
Apr 25 83.33 78.44
83.34
78.22
429.66K 5.20%
 
Apr 22 79.21 83.25
83.32
78.30
542.56K -5.31%
Apr 21 83.65 85.66
87.13
82.87
845.13K -1.62%
Apr 20 85.03 82.81
85.62
80.76
531.31K 3.14%
Apr 19 82.44 77.97
84.83
77.86
563.22K 5.05%
Apr 18 78.48 84.24
84.24
77.80
468.87K -6.84%
Apr 14 84.24 86.84
87.19
83.78
383.89K -2.94%
Apr 13 86.79 82.00
86.88
81.85
359.09K 5.07%
Apr 12 82.60 83.98
86.46
82.00
424.45K 0.44%
Apr 11 82.24 83.70
85.48
81.50
303.53K -4.43%
Apr 8 86.05 85.43
87.21
84.19
389.21K 0.02%
Apr 7 86.03 84.86
88.14
83.79
351.78K 0.86%
Apr 6 85.30 85.44
85.70
82.71
454.11K -2.07%
Apr 5 87.10 90.15
90.15
86.35
444.50K -3.11%
Apr 4 89.90 88.46
90.63
87.24
670.15K 2.56%
Apr 1 87.66 83.00
87.71
82.10
624.31K 5.81%
Mar 31 82.85 83.75
84.89
82.45
399.41K -1.45%
Mar 30 84.07 84.01
86.15
83.18
377.63K -0.53%